Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Return on Equity (2016 - 2025)

Fennec Pharmaceuticals filings provide 15 years of Return on Equity readings, the most recent being 0.0% for Q4 2025.

  • On a quarterly basis, Return on Equity changed 0.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 0.0% change, with the full-year FY2025 number at 0.01%, up 1.0% from a year prior.
  • Return on Equity hit 0.0% in Q4 2025 for Fennec Pharmaceuticals, down from 0.01% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.05% in Q1 2023 to a low of 2.02% in Q4 2022.
  • Median Return on Equity over the past 5 years was 0.0% (2024), compared with a mean of 0.1%.
  • Biggest five-year swings in Return on Equity: tumbled -201bps in 2022 and later surged 203bps in 2023.
  • Fennec Pharmaceuticals' Return on Equity stood at 0.01% in 2021, then tumbled by -26845bps to 2.02% in 2022, then soared by 101bps to 0.01% in 2023, then tumbled by -102bps to 0.0% in 2024, then plummeted by -453bps to 0.0% in 2025.
  • The last three reported values for Return on Equity were 0.0% (Q4 2025), 0.01% (Q3 2025), and 0.02% (Q2 2025) per Business Quant data.